• Anniversary Agenda: A Preview of #BioIT17

    Bio-IT World At the end of this month, Bio-IT World celebrates a milestone: the 15th anniversary of the Bio-IT World Conference & Expo. Fifteen years after we launched the event, it has grown into a community that we are proud of, a community of clever, innovative people working from all sides on the problems affecting life sciences. But we’re excited about more than just a champagne toast at this year’s celebration. Our 15th anniversary program in Boston, May 23-25, might be the best yet.

    May 3, 2017
  • Heymann and Bhowmik Launch Converge Boston’s Latest Venture Firm

    Xconomy | Boston's tech investing landscape has changed a lot in the past couple of years, with a wave of new early-stage funds popping up. That activity continued this week with the unveiling of Converge.

    May 3, 2017
  • Science Wins Reprieve In US Budget Deal

    Nature News & Comment | Congress gives National Institutes of Health a big boost and avoids cuts to research agencies sought by Trump.

    May 2, 2017
  • Personalis, Dovetail Genomics, DataDirect Networks, And More: News From April 2017

    Bio-IT World Brief | News, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Personalis, Dovetail Genomics, DataDirect Networks, and more.

    Apr 27, 2017
  • BioRxiv Preprint Server Gets Cash Boost From Chan Zuckerberg Initiative

    Nature News & Comment | Money will be used to develop open-source platform and help put articles in web-friendly formats.

    Apr 26, 2017
  • NovaSeq Orders Bring Pleasant Surprises, Says deSouza

    Bio-IT World Illumina held its first quarter earnings calls yesterday. Francis deSouza, President and CEO, reported that the launch of the company’s new sequencing platform, NovaSeq, “surpassed our expectations, with more than 135 orders in Q1.” “As far out as we can see, there’s an insatiable demand for high throughput sequencing,” deSouza said.  

    Apr 26, 2017
  • Four Decades Of Hacking Biotech And Yet Biology Still Consumes Everything

    Forbes | Computer-aided drug design is a key contributor to pharma R&D today, but its just one of many contributors. Biology still consumes everything, and is the real constraint on developing new medicines today. Healthy, realistic skepticism regarding recent "software-eats-biotech" claims is needed.

    Apr 26, 2017
  • Genomenon Wins $1.8M NIH Grant To Automatically Curate Genomic Literature

    Bio-IT World Brief | Genomenon today announced a $1.8M grant awarded by the National Institutes of Health. The fast-track Small Business Innovation Research grant, awarded by the National Human Genome Research Institute, will fund Genomenon's further innovation in genomic analysis, efficiently streamlining the laborious literature research and curation process leading to faster patient diagnosis.

    Apr 25, 2017
  • Biotech Is The New Digital Says MIT Media Lab Founder

    Dezeen | Biotechnology is going to "govern the next decade of thought" at research institutions like the MIT Media Lab, says its founder Nicholas Negroponte.

    Apr 25, 2017